Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Effectiveness of stem cells and platelet rich plasma in the treatment of oral submucous fibrosis.

Created on 09 Jul 2026

Authors

Sushmit Priyam Bora, Satyajit Dandagi, Bheemappa Bangennavar, Anu Jose, Sunny Sinh Digwa, K R Ragini Das

Published in

National journal of maxillofacial surgery. Volume 17. Issue 2. Pages 256-260. Epub Jun 03, 2026.

Abstract

Medical management of oral submucous fibrosis which is a common precancerous condition affecting population of Asian descent is still under investigations. Various modalities of medical management are detailed in the literature with varying degree of success. The major aim of the study is to evaluate the outcomes of platelet rich plasma and stem cells in the medical management of oral sub mucous fibrosis.
Ten patients diagnosed with stage II, III and IV oral submucous fibrosis were included in the study. The stem cells and PRP derived from patients peripheral blood were injected intraorally into the areas of fibrosis. Mouth opening were recorded at the follow up visits.
All patients showed satisfactory results at the end of 6 months follow up interval. Mouth opening has improved post treatment; however we suggest a long term study with more number of patients.
Stem cells and PRP can be a new effective modality for medical management of oral submucous fibrosis which requires detailed scientific studies.

PMID:
42422781
Bibliographic data and abstract were imported from PubMed on 09 Jul 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 5
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement